Conference Coverage

Fasting glucose fluctuations, severe hypoglycemia up T2DM death risk

Publish date: October 3, 2017

 

Pages

Recommended Reading

Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrate
MDedge Endocrinology
CONCEPTT: Continuous glucose monitoring during pregnancy benefits baby
MDedge Endocrinology
Wound expert: Consider hyperbaric oxygen therapy for diabetic foot ulcers
MDedge Endocrinology
Roux-en-Y gastric bypass produced durable clinical improvements at 12 years
MDedge Endocrinology
Empagliflozin’s effects independent of CVD risk factors
MDedge Endocrinology
Delayed-release metformin proves promising for diabetic renal disease
MDedge Endocrinology
FDA approves first non–finger-stick glucose monitoring system
MDedge Endocrinology
Skin autofluorescence predicts 4-year CVD risk in diabetes
MDedge Endocrinology
New ADA hypertension and diabetes treatment guide features visual aid
MDedge Endocrinology
Many years on metformin linked to anemia risk
MDedge Endocrinology